Application

19345445 · METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY

Filed 2025-09-30 · Granted · Patent 12560596 (2026-02-24) The official file ↗The patent and its PDF ↗ · Art unit 1657 · Examiner Satyendra K Singh Typical · CPC A61M 5/168 · Horizon Therapeutics USA, Inc. · AMGEN INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.0 mo

to disposition 4.8 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.